Alexis C. Geppner, MLS, CTTS, PA-C, on ALL and Hyper C-VAD: Lessons Learned and New Approaches

Alexis C. Geppner, MLS, CTTS, PA-C, of The University of Texas MD Anderson Cancer Center, discusses key data that advanced practitioners need to know about treatment for patients with acute lymphocytic leukemia, the shift away from intensive chemotherapy with the use of monoclonal antibodies and tyrosine kinase inhibitors, and whether overall responses and survival can be maintained or improved.